GETI-B:STO
Getinge publ AB
SEKÂ 183,55
arrow_downward
-1,10%(-2,05) 1D
30 Apr., 17:00:00 GMT+2 · SEK
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for GETI-B...
Open
SEKÂ 184,70
High
SEKÂ 185,95
Low
SEKÂ 181,90
Mkt. cap
46,65Â mjd
Avg. vol.
685,29Â k
Volume
1,29Â m
Dividend
2,59%
Quarterly dividend
SEKÂ 1,19
Ex dividend date
22 Apr. 2026
P/E ratio
21,19
52-wk high
SEKÂ 231,60
52-wk low
SEKÂ 175,90
EPS
SEKÂ 8,66
Shares outstanding
254,15Â m
No. of employees
12Â k
News stories
From sources across the web
MarketBeat
·
4 minute gelede
Ichor Holdings, Ltd. (NASDAQ:ICHR) Given Consensus Recommendation of "Moderate Buy" by Brokerages
Simply Wall Street
·
42 minute gelede
A Look At IREN (NasdaqGS:IREN) Valuation As Its AI Pivot Draws Fresh Analyst Attention
WSJ
·
47 minute gelede
S&P 500 Extends Longest Weekly Winning Streak Since Late 2024
Simply Wall Street
·
59 minute gelede
Is It Too Late To Consider Dow (DOW) After Its 66% Year To Date Rally?
Profile
Getinge AB is a publicly traded Swedish medical technology company. The company produces and distributes medical products and equipment for the healthcare and life sciences industries. The company is divided into three business areas: Life Science, Acute Care Therapies, and Surgical Workflows. The group employs approximately 12,000 people worldwide. The CEO of the company is Mattias Perjos, and the chairman of the board is Johan Malmquist. With a sales share of around 40%, the United States is by far the most important market for the company due to significantly higher prices and margins there. China and various Western European countries follow. Wikipedia
About Getinge publ AB
AI content may include mistakes. Learn more